Related Experiment Video
Updated: Sep 26, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Survival After Intervention for Single-Ventricle Heart Disease Over 15 Years at a Single Institution
Alexander Zhu1, James M Meza1, Neel K Prabhu1
1Department of Surgery, Duke Children's Pediatric & Congenital Heart Center, Duke Children's Hospital, Durham, North Carolina.
Insights
Survival in single-ventricle (SV) heart disease varies by anatomy and procedure. Less invasive interventions and achieving a two-ventricle circulation improve outcomes for children with SV heart disease.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Outcomes
Background:
- Single-ventricle (SV) heart disease encompasses diverse malformations with similar hemodynamics.
- Outcome disparities suggest influence of morphology, patient factors, and interventions.
Purpose of the Study:
- To comprehensively review survival rates after interventions for SV heart disease.
- To identify factors influencing survival in pediatric SV heart disease patients.
Main Methods:
- Defined SV heart disease and stratified patients into diagnostic and procedural groups.
- Analyzed 10-year survival data for 381 patients undergoing intervention between 2005-2020.
Main Results:
- Ten-year survival ranged from 55% (hypoplastic left heart syndrome) to 89% (double inlet left ventricle).
- Less invasive procedures (ductal stent, pulmonary artery banding) showed superior survival compared to Norwood procedure.
- Achieving biventricular circulation (87%) improved survival over remaining SV physiology (63%).
- Risk factors for mortality included chromosomal abnormalities, low weight, hybrid Norwood, non-left ventricular dominance, and earlier operations.
Conclusions:
- Survival in SV heart disease is linked to cardiac anatomy, patient characteristics, and procedural complexity.
- Left ventricular dominance, recent interventions, and biventricular circulation attainment correlate with better survival.
Background:
Children with single-ventricle (SV) heart disease possess a spectrum of heart malformations, yet progress through similar hemodynamic states, suggesting differences in outcomes are related to fundamental morphologic differences, patient characteristics, or procedural pathways. We sought to provide a holistic overview of survival after intervention for SV heart disease at our institution.
Methods:
SV heart disease was defined as patients born with a hypoplastic or dysfunctional ventricle with uncertain or unacceptable candidacy for a 2-ventricle circulation. Patients were stratified into 8 diagnostic groups and 11 procedural categories based on the initial interventional procedure.
Results:
Between 2005 and 2020, 381 patients born with SV heart disease underwent intervention at our institution. Ten-year survival was highest for patients with double inlet left ventricle (89% ± 7%) and lowest for patients with hypoplastic left heart syndrome (55% ± 5%). Initial palliation with less invasive procedures, such as ductal stent (4-year: 100%) or pulmonary artery banding (10-year: 95% ± 5%), demonstrated superior survival compared with more invasive procedures such as the Norwood procedure (10-year: 59% ± 4%). Survival of patients who achieved a biventricular circulation was superior to patients who remained with SV physiology (10-year: 87% ± 5% vs 63% ± 3%, P = .04). In a multivariable analysis, chromosomal/syndromic abnormality, lower weight, hybrid Norwood procedure, nonleft ventricular dominance, and earlier year of operation were risk factors for death.
Conclusions:
Survival differences in patients with SV heart disease were related primarily to underlying cardiac anatomy, patient characteristics, and procedural complexity. Left ventricular dominance, more recent intervention, and attainment of a 2-ventricle circulation were associated with improved survival.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Mitral Stenosis III: Medical Management
Heart Failure V: Medical Management
Mitral Stenosis I: Introduction

